skip to main content

    Updated Visitor Guidelines

 

MENU

 

Sarcoma Clinical Trials

The information on this page has moved. Search for clinical trials on our Find a Clinical Trial page or contact Cancer AnswerLine for help at 800-865-1125.

Colon Cancer Clinical Trials

The information on this page has moved. Search for clinical trials on our Find a Clinical Trial page or contact Cancer AnswerLine for help at 800-865-1125.

Brain Cancer Clinical Trials

The information on this page has moved. Search for clinical trials on our Find a Clinical Trial page or contact Cancer AnswerLine for help at 800-865-1125.

Bone Marrow Transplant Clinical Trials

The information on this page has moved. Search for clinical trials on our Find a Clinical Trial page or contact Cancer AnswerLine for help at 800-865-1125.

Bone Cancer Clinical Studies

The information on this page has moved. Search for clinical trials on our Find a Clinical Trial page or contact Cancer AnswerLine for help at 800-865-1125.

Immune cells found to fuel colon cancer stem cells

A subset of immune cells directly target colon cancers, rather than the immune system, giving the cells the aggressive properties of cancer stem cells. The researchers are now looking at potential drugs that might target this process directly.

Adrenal Cancer Clinical Trials

The information on this page has moved. You can now search for clinical trials on our Find a Clinical Trial web page or contact Cancer AnswerLine at 800-865-1125 for assistance.

Unemployment common after breast cancer treatment

Researchers surveyed woman in Detroit and Los Angeles who had been diagnosed with early stage breast cancer. They narrowed their sample to the 746 women who reported working at the time they were diagnosed. Participants were surveyed about nine months after diagnosis, and then given a follow-up survey about four years later.

New target for prostate cancer resistant to anti-hormone therapies

Prostate cancer becomes deadly when anti-hormone treatments stop working. Now a new study suggests a way to block the hormones at their entrance.

Researchers from the University of Michigan Rogel Cancer Center have found that a protein called BET bromodomain protein 4 binds to the hormone androgen receptor downstream of where current therapies work – targeting androgen receptor signaling.

Make a Gift to Pancreatic Cancer Research

At the University of Michigan, we believe that our unique interdisciplinary approach to pancreatic cancer research sets us on the path toward mastering early detection, arresting metastasis and extending the quantity and quality of life for pancreatic cancer patients in 5-10 years, but we can't do it without resources to support our research.

Pages